HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$10.26
Day range
$9.85 - $10.88
Year range
$3.21 - $18.33
Market cap
2.80B USD
Avg Volume
5.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 715.00K | — |
Operating expense | 111.18M | 0.29% |
Net income | -112.98M | -5.22% |
Net profit margin | -15.80K | — |
Earnings per share | -0.42 | 16.00% |
EBITDA | -110.11M | -1.87% |
Effective tax rate | 1.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 356.20M | -43.13% |
Total assets | 869.83M | 5.46% |
Total liabilities | 189.81M | 20.22% |
Total equity | 680.02M | — |
Shares outstanding | 279.83M | — |
Price to book | 4.22 | — |
Return on assets | -35.67% | — |
Return on capital | -41.31% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -112.98M | -5.22% |
Cash from operations | -122.28M | -22.51% |
Cash from investing | -111.51M | -172.69% |
Cash from financing | 193.58M | -25.02% |
Net change in cash | -40.70M | -113.06% |
Free cash flow | -82.41M | -32.83% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
557
